Arsenic Toxicity Supportive Care Protocol

Arsenic poisoning occurs from exposure to inorganic arsenic through contaminated drinking water (common in parts of Bangladesh, India, and other regions), occupational exposure, or less commonly through food. Chronic arsenic exposure causes a wide range of health problems including skin lesions, cancer (skin, lung, bladder), cardiovascular disease, diabetes, and neurological effects. Acute high-dose exposure can cause severe GI symptoms, multi-organ failure, and death.

CRITICAL: Arsenic poisoning requires medical management. The primary treatment is removing the source of exposure and, for acute or high-level poisoning, medical chelation therapy (DMSA, DMPS, or BAL). These supplements support the body's natural detoxification and antioxidant systems but do NOT replace medical treatment for arsenic toxicity. If you suspect arsenic exposure, have your water tested and blood/urine arsenic levels checked. Work with a toxicologist or occupational medicine specialist.

* N-Acetyl Cysteine (NAC) is a precursor to glutathione, the body's primary antioxidant and detoxification molecule. Arsenic depletes glutathione and causes massive oxidative stress. NAC helps restore glutathione levels and protect against arsenic-induced damage.

* Selenium has a unique interaction with arsenic - it can form complexes with arsenic that are excreted more easily. Selenium also supports glutathione peroxidase, an important antioxidant enzyme. Studies in arsenic-affected populations show selenium supplementation can reduce arsenic toxicity markers.

* Curcumin has potent antioxidant and anti-inflammatory effects that may help protect organs from arsenic-induced damage.

* Alpha-Lipoic Acid is an antioxidant that may have mild chelating properties for metals and helps regenerate other antioxidants like vitamins C and E.

* Vitamins C and E provide additional antioxidant protection against the severe oxidative stress caused by arsenic.

* Zinc supports the production of metallothioneins, proteins that can bind and help detoxify heavy metals including arsenic.

Expected timeline: For chronic low-level exposure, improvement occurs over months to years after removing the exposure source. Supplements provide ongoing protection. For acute poisoning, medical chelation therapy is needed urgently.

Clinical Perspective

Arsenic toxicity: inorganic arsenic (As3+, As5+) more toxic than organic forms. Sources: contaminated groundwater (widespread in South Asia), industrial exposure, pesticides, wood preservatives, some traditional medicines. Acute toxicity: GI symptoms, hemolysis, QT prolongation, encephalopathy, ARDS, multi-organ failure. Chronic toxicity: keratoses, melanosis, cancer (skin, lung, bladder), cardiovascular disease, diabetes, peripheral neuropathy.

CRITICAL: Primary intervention is elimination of exposure. Medical chelation: DMSA (succimer) 10mg/kg TID for mild-moderate; BAL (dimercaprol) + DMSA for severe. Supportive care for acute toxicity. Supplements are ADJUNCTIVE - do not replace chelation for significant toxicity. Urinary arsenic levels guide treatment (>100mcg/L concerning, >50mcg/L warrants evaluation).

* NAC (B-grade): Glutathione precursor; enhances arsenic methylation and excretion. Systematic review: protective effects (PMID: 25614138). Study: reduces oxidative markers (PMID: 19153878). 600-1200mg BID.

* Selenium (B-grade): Forms As-Se complex for excretion; supports GSH-Px. Clinical trial: reduced toxicity markers in exposed population (PMID: 24316390). Review: As-Se interaction (PMID: 17697154). 100-200mcg daily. Don't exceed 400mcg.

* Curcumin (C-grade): Antioxidant; Nrf2 activation. Experimental study: hepatoprotective against arsenic (PMID: 23895540). 500-1000mg enhanced-absorption daily.

* Alpha-Lipoic Acid (C-grade): Antioxidant; mild chelator. Review: arsenic protection mechanisms (PMID: 20358242). 300-600mg daily.

* Vitamin C (C-grade): Antioxidant. Study: supplementation in exposed populations (PMID: 19150463). 500-1000mg daily.

* Vitamin E (C-grade): Lipid-soluble antioxidant. Experimental: protects cell membranes (PMID: 18296328). 400 IU daily.

* Zinc (C-grade): Metallothionein induction. Study: reduced toxicity markers (PMID: 21186369). 15-30mg daily.

Biomarker targets: Urinary total arsenic (spot or 24h), speciated arsenic (inorganic vs organic), complete blood count, LFTs, renal function, ECG (QT interval).

Protocol notes: Identify and eliminate source: water testing, occupational history, rice/seafood consumption (organic arsenic). Water arsenic >10ppb (WHO limit) requires intervention. Arsenic-removal water filters or alternative water sources. Chelation: DMSA (succimer) preferred for chronic/mild-moderate - 10mg/kg TID x 5 days, off 2 weeks, repeat 3 cycles. BAL for acute severe toxicity. IV chelation for severe encephalopathy. Supportive: IV fluids, hemodialysis for ARF, blood transfusion for hemolysis. Monitoring: arsenic levels, organ function. Chronic effects may progress after exposure stops. Cancer screening: skin surveillance, consider bladder, lung monitoring. Cardiovascular risk management. Diabetes screening. Neuropathy: may be irreversible. Workplace exposure: regulatory compliance, PPE, removal from exposure. Epidemiological considerations in endemic areas.

View All Protocols